A novel bone implant with enhanced bone healing capacity
The objective of the project is to bring the first bone implant with enhanced bone healing capacity to the market and clinical practice. The market demand for bone implants is steadily increasing driven by aging populations, incre...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
GIOTTO
Active aGeIng and Osteoporosis The next challenge for smarT...
6M€
Cerrado
NanoBOOST
Nano Engineered Injectable Biomaterials for Osteoporotic Bon...
185K€
Cerrado
REBOOT
First in class implants for bone regeneration surgery after...
4M€
Cerrado
CHARME
Growing bone fast and cost effective
3M€
Cerrado
SAF2008-03446
DIFUSION CONTROLADA DE FARMACOS ENCAPSULADOS EN SISTEMAS DE...
109K€
Cerrado
EOBOTE
Study of Endothelial and Osteoclastic cells cooperation for...
75K€
Cerrado
Información proyecto CERAMENT-BC
Duración del proyecto: 6 meses
Fecha Inicio: 2016-08-22
Fecha Fin: 2017-02-28
Líder del proyecto
BONE SUPPORT AB
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The objective of the project is to bring the first bone implant with enhanced bone healing capacity to the market and clinical practice. The market demand for bone implants is steadily increasing driven by aging populations, increased demand for high quality of life and an increasing number of joint reconstruction surgeries. Enhancement of the bone healing process is often necessary, especially for patients with larger bone voids and gaps. The existing clinical methods targeting this need are based on the combination of Bone Graft Substitutes (BGS) with:
• systemic treatment with Bone Active Drug (BAD), or
• the off-label use of the BAD.
Both alternatives create risks for side-effects and complications.
BONESUPPORT will move beyond the current state of the art and propose CERAMENT-BC – the first product combining a BGS with a BAD (bisphosphonate), enhancing the healing capacity of the implant. The commercial potential of this nano-modified material lies in the efficient local delivery of the drug to the targeted skeletal side, minimizing side-effects and improving quality of life for the patient.
The targeted users are orthopedic surgeons who need new methods for the enhancement of the bone healing process, reduction of secondary fractures and postoperative complications. CERAMENT-BC will meet those needs by combining the advantages of BGS and BAD and thus providing both fracture stability and a local therapeutic effect.
The Phase 1 study will develop a business plan for the commercialisation of the product. Assuring cost-efficient and innovative approaches to the treatment of musculoskeletal conditions is an EU-wide challenge. The project will address this challenge by proposing a new treatment option which for the first time combines an injectable biomaterial with a BAD.